However, the TF-mRNA-miRNA network analysis with the hub genes and the recent trend of targeting TF in cancer therapy (Bushweller, 2019) highlight the importance of identifying common transcriptional and post-transcriptional regulators for the hub genes, such as TFDP1 and miR-1-3p. The gene discussed is TF; the disease is cancer.